LEADING LIGHT FOR LIFE
LIVE

Serial Number

79102816

Owner

ASTELLAS PHARMA INC.

Attorney

Karen Lim

Filing Date

Jul 22, 2011

Add to watchlist:

No watchlists yet
View on USPTO

LEADING LIGHT FOR LIFE Trademark

Serial Number: 79102816 • Registration: 4192508

LEADING LIGHT FOR LIFE is a trademark filed by ASTELLAS PHARMA INC. on July 22, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ASTELLAS PHARMA INC. (257 trademarks)

3-11 NIHONBASHI-HONCHO 2-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

July 22, 2011

Registration Date

August 21, 2012

Published for Opposition

June 5, 2012

Cancellation Date

July 22, 2021

Goods & Services

[ Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides ]

[ Testing, inspection or research of pharmaceuticals; ] providing medical research information in the field of pharmaceuticals

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2022 DETH
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 21, 2021 REM4
NEW REPRESENTATIVE AT IB RECEIVED
Oct 23, 2020 NREP
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jan 8, 2020 CORV
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2019 CRFA
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 6, 2018 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 7, 2018 INPS
INVALIDATION PROCESSED
Jun 7, 2018 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 5, 2018 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 5, 2017 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 5, 2017 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 5, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 5, 2017 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 21, 2017 REM3
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jul 15, 2013 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 13, 2013 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 31, 2013 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2012 FINV
NOTIFICATION PROCESSED BY IB
Dec 10, 2012 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 29, 2012 FICS
FINAL DISPOSITION PROCESSED
Nov 29, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 21, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 21, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 5, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jun 5, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 16, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 16, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 28, 2012 PREV
ASSIGNED TO LIE
Apr 24, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2012 TROA
REFUSAL PROCESSED BY IB
Nov 20, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 28, 2011 RFCS
REFUSAL PROCESSED BY MPU
Oct 28, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2011 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2011 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 14, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2011 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 7, 2011 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 6, 2011 REPR